Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
35.47
+3.58 (11.23%)
At close: Jun 18, 2026, 4:00 PM EDT
35.25
-0.22 (-0.62%)
After-hours: Jun 18, 2026, 7:59 PM EDT

Hims & Hers Health Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Hims & Hers Health stock has a consensus rating of "Hold" and an average price target of $27.32. The average 1-year stock price forecast is 22.98% lower than the current stock price, while the lowest is $21 (-40.80%) and the highest is $39 (+9.95%).

Price Target: $27.32 (-22.98%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$21$27.32$25$39
Change-40.80%-22.98%-29.52%+9.95%

Analyst Ratings

The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy211111
Buy122333
Hold101012121211
Sell110001
Strong Sell110000
Total151515161616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Maintains
$29$39
BuyMaintains$29$39+9.95%Jun 18, 2026
Truist Financial
Truist Financial
Hold
Reiterates
n/a
HoldReiteratesn/an/aJun 9, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$32
BuyMaintains$32-9.78%Jun 3, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$28$25
HoldMaintains$28$25-29.52%May 26, 2026
Jefferies
Jefferies
Hold
Maintains
$26$25
HoldMaintains$26$25-30.93%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.15B
from 2.35B
Increased by 34.26%
Revenue Next Year
4.46B
from 3.15B
Increased by 41.56%
EPS This Year
0.36
from 1.10
Decreased by -67.32%
EPS Next Year
0.89
from 0.36
Increased by 147.22%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
271.88M526.92M872.00M1.48B2.35B3.15B
Revenue Growth
82.77%93.81%65.49%69.33%59.00%34.26%
Gross Profit
204.49M408.72M714.95M1.17B1.73B2.11B
Gross Margin
75.22%77.57%81.99%79.45%73.84%67.10%
Operating Income
-106.94M-66.38M-26.44M65.88M121.16M-5.77M
Net Income
-107.66M-65.68M-23.55M126.04M128.37M-19.60M
EPS
----1.100.36
EPS Growth
----16.23%-67.32%
Forward PE
---47.3155.1098.53
Free Cash Flow
52.46M-44.35M66.38M178.62M110.51M103.40M
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.2B
Avg3.2B
Low3.2B

Revenue Growth

Revenue Growth202620272028
High
34.3%
Avg
34.3%
Low
34.3%

EPS Forecast

EPS202620272028
High0.36
Avg0.36
Low0.36

EPS Growth

EPS Growth202620272028
High
-67.3%
Avg
-67.3%
Low
-67.3%